Intrinsic Value of S&P & Nasdaq Contact Us

Cemtrex, Inc. CETX NASDAQ

NASDAQ Capital Marke • Technology • Software - Infrastructure • US • USD

SharesGrow Score
42/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$24,633.00
+2035685.1%

Cemtrex, Inc. (CETX) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 2 Buy, 1 Hold.

The consensus price target is $24,633.00, representing an upside of 2035685.1% from the current price $1.21.

Analysts estimate Earnings Per Share (EPS) of $-15,435.00 and revenue of $0.07B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-509.98 vs est $-15,435.00 (beat +96.7%). 2025: actual $-210.88 vs est $17,010.00 (missed -101.2%). Analyst accuracy: 0%.

CETX Stock — 12-Month Price Forecast

$24,633.00
▲ +2,035,685.12% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for Cemtrex, Inc., the price target is $24,633.00.
The average price target represents a +2,035,685.12% change from the last price of $1.21.

CETX Analyst Ratings

Buy
3
Ratings
2 Buy
1 Hold
Based on 3 analysts giving stock ratings to Cemtrex, Inc. in the past 3 months
Rating breakdown
Buy
2 67%
Hold
1 33%
67%
Buy
2 analysts
33%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — CETX

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$509.98 vs Est –$15,435.00 ▲ 2,926.6% off
2025 Actual –$210.88 vs Est $17,010.00 ▼ 8,166.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — CETX

98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.067B vs Est $0.068B ▼ 2.1% off
2025 Actual $0.076B vs Est $0.079B ▼ 2.6% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message